首页> 美国卫生研究院文献>Journal of Clinical Oncology >Phase II Study of Modified Docetaxel Cisplatin and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

【2h】

Phase II Study of Modified Docetaxel Cisplatin and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

机译：贝伐单抗修饰多西他赛顺铂和氟尿嘧啶治疗转移性胃食管腺癌的II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo evaluate the safety and efficacy of a modified administration schedule of docetaxel, cisplatin, and fluorouracil (mDCF) with bevacizumab in patients with advanced gastroesophageal malignancies.

机译：目的评估改良的多西他赛，顺铂和氟尿嘧啶（mDCF）与贝伐单抗联合给药方案对晚期胃食管恶性肿瘤患者的安全性和有效性。

著录项

期刊名称 Journal of Clinical Oncology
作者
Manish A. Shah; Minaxi Jhawer; David H. Ilson; Robert A. Lefkowitz; Edric Robinson; Marinela Capanu; David P. Kelsen;
展开▼
作者单位

展开▼
年(卷),期 -1(29),7
年度 -1
页码 868–874
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. [J] . Shah MA, Jhawer M, Ilson DH, Journal of Clinical Oncology . 2011 ,第7期

机译：改良的多西他赛，顺铂和氟尿嘧啶与贝伐单抗在转移性胃食管腺癌患者中的II期研究。
2. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India [J] . Babu K. G., Chaudhuri T., Lakshmaiah K. C., Indian journal of cancer. . 2017 ,第1期

机译：一线全身化疗与表皮苷，顺铂加5-氟尿嘧啶和多西紫杉醇，顺铂加5-氟尿嘧啶方案的疗效和安全性在局部先进的不可操作或转移性胃或胃食管接合腺癌腺癌腺癌：II南印度的预期研究
3. Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium [J] . Shah Manish A., Janjigian Yelena Y., Stoller Ronald, Journal of Clinical Oncology . 2015 ,第33期

机译：改良多西他赛，顺铂和氟尿嘧啶（DCF）与DCF加上生长因子支持治疗转移性腺癌患者的多中心随机II期研究：美国胃癌联合会的研究
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group [O] . Nikolaos Kentepozidis, Panagiota Economopoulou, Michael Liontos, 2018

机译：Panitumumab联合修饰的多西他赛/顺铂/ 5-氟尿嘧啶作为胃和胃食管连接腺癌的一线治疗：希腊肿瘤研究小组进行的多中心II期研究
7. Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma [O] . Manish A. Shah, Minaxi Jhawer, David H. Ilson, 2011

机译：转移胃肠腺癌患者的改性多西紫杉醇，顺铂和氟尿嘧啶的II期研究

Phase II Study of Modified Docetaxel Cisplatin and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

摘要

著录项

相似文献

相关主题

期刊订阅